Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccineCase Reports Published on 2022-11-302023-07-08 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] Acute interstitial nephritis Adolescent BNT162b2 mRNA COVID-19 vaccine Child Control COVID-19 pandemics/prevention & SARS-CoV-2 vaccination. [DOI] 10.1080/21645515.2022.2059308 PMC 바로가기 [Article Type] Case Reports
Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control studyArticle Published on 2022-11-302022-11-15 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 진단, [키워드] age anti-SARS-CoV-2 antibodies antibody Antibody Response Case-control case-control study China confidence interval Control COVID-19 infection COVID-19 pandemic Department dose Hospitalization hospitalization. hospitalized patient inactivated lack management Odds ratio participant Participants Protective SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine seroconversion rate seronegative seronegative participant seropositive participant Sex Sinopharm tested the antibody response the SARS-CoV-2 the vaccine Urology vaccination Vaccine was obtained were assessed [DOI] 10.1080/21645515.2022.2088966 PMC 바로가기
The heterogeneous mixing model of COVID-19 with interventionsArticle Published on 2022-11-212022-11-16 Journal: Journal of theoretical biology [Category] 변종, [키워드] Admission age analyzed Breakthrough infection caused China conducted Control Control reproduction number Coverage COVID-19 COVID-19 transmission death effective Effectiveness Epidemic evaluate Future group heterogeneity heterogeneous Heterogeneous mixing Infection Intervention manuscript measure mechanism mutant strain Mutant strains Prevent Prevent infection preventing infection reduce Reproduction number stability submitted Transmission vaccination vaccination strategies. Vaccination strategy Vaccine Vaccines [DOI] 10.1016/j.jtbi.2022.111258 PMC 바로가기
Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020Transformations Published on 2022-11-172022-11-01 Journal: Epidemiology and Infection [Category] COVID-19, MERS, [키워드] 95% CI 95% confidence interval activity age alcohol case-control study close contact Community Community acquired infections conducted Contact Control controls country COVID-19 Denmark determinant determinants disease event Evidence household size identification Infection investigated National Odds ratio Other Participants performed positive preventive measures reduce Risk factors RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections Sex telephone tested took place Transmission Transport Travel [DOI] 10.1017/S0950268821002478 PMC 바로가기 [Article Type] Transformations
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodiesArticle Published on 2022-11-082022-11-15 Journal: Scientific Reports [Category] SARS, 치료기술, [키워드] acute respiratory syndrome administration affecting analysis Analysis anti-RBD IgG antibody anti-SARS-CoV-2 AUC automated binding antibody booster clinical settings Cohort collected Control coronavirus correlation COVID-19 cutoff value demonstrated Effectiveness Genscript gold standard Immunity immunoassay in both groups infected patient Mindray NAb neutralization Neutralization assay neutralization test neutralizing antibody population level protective immunity provide pseudovirus R 2 Rapid receiver operating characteristic Research ROC ROC Curve Sample SARS-CoV-2 SARS-CoV-2 infected patient second dose sensitivity shown significantly specificity subjects sVNT sVNT assay symptoms onset tested threshold vaccinated individual Vaccine virus neutralization test was performed [DOI] 10.1038/s41598-022-21317-x PMC 바로가기
High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasoneArticle Published on 2022-11-052022-11-15 Journal: Respiratory Research [Category] SARS, 바이오마커, [키워드] Admission association Biomarker Biomarkers Blood level Clinical management Control correlated covariates COVID-19 COVID-19 patient COVID-19 patients death Determination Dexamethasone died disease severity elevated Follow-up greater host inflammatory response IL-6 increased risk independent Infection Inflammation investigated Mortality NEWS2 Patient patient population patients patients treated Pearson positive positive individual predict prognostic RAGE receptor reduce risk SARS-CoV-2 score second wave significantly lower sRAGE. subject Teaching treated Treatment university [DOI] 10.1186/s12931-022-02220-5 PMC 바로가기
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal sheddingArticle Published on 2022-11-042022-11-16 Journal: Scientific Reports [Category] SARS, 변종, [키워드] Analysis asked both groups clade Consequences Control COVID 19 deviation Evolution of SARS-CoV-2 genomic greater Human immune system immune evasion increase Infectious virus Interaction intra-individual investigated Mutation N501Y nasopharyngeal no significant difference P681H pandemic Patient patients performed persistence Prevent question RNA virus SARS-CoV-2 Sequencing Standard survival the SARS-CoV-2 therapeutic two group Variability variants viral propagation viral variant [DOI] 10.1038/s41598-022-22060-z PMC 바로가기
Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infectionArticle Published on 2022-11-012022-11-15 Journal: Chemico-biological interactions [Category] SARS, 변종, 치료제, [키워드] ACE2 Analysis angiotensin-converting enzyme 2 Anti-inflammatory anti-inflammatory activity antiviral drug approach approved combating Compound contribute Control COVID-19 COVID-19 infection COVID-19 patients cytokine Efficacy ELIXIR entry of SARS-CoV-2 expression FDA GC-MS group groups hamster hamsters human host in silico in vivo in-silico Infection inhibiting inhibitory effect investigated Lung injury male membrane molecular docking molecular docking studies new SARS-CoV-2 PCR Polyherbal oil Prophylactic Protective real time receptor reduced respiratory diseases SARS-CoV-2 selected significantly Spike protein the SARS-CoV-2 Therapeutics Therapeutics. these compound treat Treatment treatment groups Vaccine variants viral envelope Viral load [DOI] 10.1016/j.cbi.2022.110179 PMC 바로가기
Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximabArticle Published on 2022-11-012022-11-15 Journal: International journal of urology : official journa [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome affected antibody antigen-specific T cell baseline cellular response Control controls coronavirus coronavirus disease COVID-19 demonstrated Deterioration dose enrolled enzyme-linked immunospot enzyme-linked immunospot assay evaluated healthcare worker healthy control humoral immunogenicity kidney Kidney function kidney transplant recipient kidney transplant recipients Kidney transplantation lack low-dose mRNA mRNA vaccine multivariate regression analysis not affect not significantly different profiles rituximab. SARS-CoV-2 Seroconversion seroconversion rate Spike protein systemic adverse event the vaccine treatment history vaccination Vaccine [DOI] 10.1111/iju.14978 PMC 바로가기
Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replicationArticle Published on 2022-11-012022-11-15 Journal: Journal of biomolecular structure & dynamics [Category] SARS, 치료제, [키워드] added antibiotic antimalarial Antiviral approved binding domain Bruton tyrosine kinase inhibitors China claimed contagious Control country COVID-19 pandemic Dependent disease domain drug drug design FDA in viral in-depth analysis increase Infection inhibiting inhibitor Interaction interfere M pro MD simulation number of infected outbreak Papain Population protease provide Psychological distress quinoline based FDA approved Drugs. RBD Remdesivir Replication required resource RNA RNA dependent RNA polymerase RNA polymerase RNA virus SARS-CoV-2 selected Spike protein spread to target Vaccines viral entry viral replication Virtual screening [DOI] 10.1080/07391102.2021.1913228 PMC 바로가기